Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-020522
Filing Date
2018-07-24
Accepted
2018-07-24 17:08:39
Documents
1
Period of Report
2018-07-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3963
  Complete submission text file 0000899243-18-020522.txt   5377
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Issuer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CRINETICS PHARMACEUTICALS, INC. 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address
Freeman Mason (Reporting) CIK: 0001745948 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38293 | Film No.: 18967069